CORT vs ELV · P/E 199, rev $421.1M vs P/E 18, rev $199.13B
Corcept Therapeutics Incorporated (CORT) versus Elevance Health Inc (ELV) — a side-by-side from cached financials, not a winner call.
Corcept Therapeutics Incorporated (CORT) is a biotechnology company listed on US.
Elevance Health Inc (ELV) is a healthcare plans company listed on US.
Latest reported CORT revenue for 2026-06-30 was $421.1M. Net income was $11.2M. CORT currently screens at market cap $7.46B and trailing P/E 198.5.
Latest reported ELV revenue for 2025-12-31 was $199.13B. Net income was $5.66B. Revenue was up 12.5% from 2024-12-31 to 2025-12-31. ELV currently screens at market cap $90.24B and trailing P/E 17.6.
CORT currently screens at market cap $7.46B and trailing P/E 198.5. ELV currently screens at market cap $90.24B and trailing P/E 17.6.
Not investment advice. Open the CORT and ELV stock pages for the full models.
Not investment advice.